Combining NAD+ therapy with GLP-1 treatment appears safe for most individuals when monitored by a healthcare professional
These compounded drugs are not approved by the FDA, and serious concerns with these drugs have been identified, including dosing errors, unapproved salt forms, and adverse events that have led to hospitalization
Mean glycated hemoglobin (HbA1c) decreased over time from baseline in the 2.510.0 mg ( 2.4%) and 2.515.0 mg ( 1.6%) tirzepatide groups, at week 16 and week 24, respectively, but remained steady in patients receiving placebo
In addition, with methylcobalamin some positive health effects can be achieved that are not possible with cyanocobalamin
Honestly, there is absolutely nothing bad I can say about this sunscreen
A comparison should start with the clinical goal